Product Review

Cluster DextrinTM is a trademarked form of Highly Branched Cyclic Dextrin that is a new type of dextrin that is produced from amylopectin via cyclization reaction of a branching enzyme (BE,1,4-α-D-glucan: 1,4-α-D-glucan 6-α-D-(1,4-α-D-glucano)-transferase,EC 2.4.1.18). Ezaki Glico has successfully achieved industrial production of Cluster Dextrin by applying its unique technology in enzymology. Glico obtained FDA Notified GRAS status for Cluster Dextrin in October 2012. Cluster Dextrin is manufactured by applying an enzyme called a branching enzyme to corns tarch . The branching enzyme works on the joint of the cluster structure of amylopectin and degrades it by cyclization. Thus, Cluster DextrinTM is considered to maintain the cluster structure, which is the basic structural unit of amylopectin, nearly as it is.